New patent expiration for Pfizer drug XELJANZ
Annual Drug Patent Expirations for XELJANZ Xeljanz is a drug marketed by Pfizer and Pf Prism Cv and is included in three NDAs. It is available from two suppliers. There…
The post New patent expiration for Pfizer drug XELJANZ appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.